JJackal

Intuitive Surgical Saved by the Bell

ARAY , manufacturer of the Cyberknife, offers a better outcome for many prostate cancers patients than a prostatectomy. Why more urologists haven't figured this out and recommended the treatment as an option to their patients is why the stock is so undervalued. If ARAY ever gets it and makes the public aware, more patients will demand this option, driving ARAY's mkt share and reducing ISRG.